<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antifungal dosing for blastomycosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antifungal dosing for blastomycosis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antifungal dosing for blastomycosis</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1_left"> </td> <td class="subtitle1_left">Adults</td> <td class="subtitle1_left">Children</td> </tr> <tr> <td rowspan="3"><strong>Amphotericin B</strong>*</td> <td class="border_bottom_white"><strong>Liposomal Amphotericin B</strong><sup>¶</sup><strong>:</strong> 3 to 5 mg/kg once daily IV.</td> <td class="border_bottom_white"><strong>Liposomal Amphotericin B</strong><sup>¶</sup><strong>:</strong> 3 to 5 mg/kg once daily IV.</td> </tr> <tr class="border_bottom_white"> <td><strong>Lipid complex Amphotericin B</strong><strong>:</strong> 5 mg/kg once daily IV.</td> <td><strong>Lipid complex Amphotericin B</strong><strong>:</strong> 5 mg/kg once daily IV.</td> </tr> <tr> <td><strong><em>Alternative:</em> Amphotericin B deoxycholate:</strong> 0.7 to 1 mg/kg once daily IV.</td> <td><strong><em>Alternative:</em> Amphotericin B deoxycholate:</strong> 0.7 to 1 mg/kg once daily IV.</td> </tr> <tr> <td rowspan="3"><strong>Oral itraconazole</strong><sup>Δ</sup><sup>◊</sup></td> <td class="border_bottom_white"><strong>Itraconazole:</strong> 200 mg three times daily for three days then 200 mg once to three<sup>§</sup> times daily.</td> <td class="border_bottom_white"> </td> </tr> <tr class="border_bottom_white"> <td><strong>Itraconazole (liquid):</strong> 200 mg three times daily for three days then 200 mg once to three<sup>§</sup> times daily.</td> <td><strong>Itraconazole (liquid):</strong> 5 mg/kg/dose twice daily; maximum dose: 200 mg/dose.</td> </tr> <tr> <td><strong>SUBA-itraconazole</strong><sup>¥</sup><strong> (capsule):</strong> 130 mg three times daily for three days then 130 mg once daily.</td> <td> </td> </tr> <tr> <td rowspan="4"><strong>Oral voriconazole</strong><sup>◊</sup><sup>‡</sup></td> <td rowspan="4">Voriconazole 200 to 400 mg twice daily.</td> <td class="border_bottom_white"><strong>&lt;2 years:</strong> Oral suspension: 9 mg/kg/dose twice daily, then adjust based on serum trough levels.</td> </tr> <tr class="border_bottom_white"> <td><strong>2 to &lt;12 years:</strong> Oral suspension: 9 mg/kg/dose twice daily; maximum dose: 350 mg/dose.</td> </tr> <tr> <td class="border_bottom_white"> <p><strong><em>12 to ≤14 years:</em></strong></p> <p class="indent1"><strong>&lt;50 kg:</strong> 9 m/g/kg/dose twice daily; maximum dose: 350 mg/dose.</p> <p class="indent1 extra_spacing_top"><strong>≥50 kg:</strong> 200 mg twice daily.</p> </td> </tr> <tr> <td> <p><strong><em>&gt;14 years:</em></strong></p> <p class="indent1"><strong>&lt;40 kg:</strong> 100 mg twice daily.</p> <p class="indent1 extra_spacing_top"><strong>≥40 kg:</strong> 200 mg twice daily.</p> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>SUBA: Super-Bioavailable.</p>
<p>* Lipid formulations of amphotericin B are preferred over amphotericin B deoxycholate because of less nephrotoxicity.</p>
<p>¶ For patients with CNS blastomycosis, 5 mg/kg/day should be used.</p>
<p>Δ Adjust dose based on trough serum concentrations. Goal troughs are &gt;1 mcg/mL (although some clinicians prefer &gt;2 mcg/mL) by high-performance liquid chromatography or &gt;3 mcg/mL by bioassay. Itraconazole oral capsules are preferred over other formulations (eg, liquid, SUBA-itraconazole) because of the available effectiveness data and better side effect profile.</p>
<p>◊ Itraconazole and voriconazole are subject to numerous clinically significant drug-drug interactions. Patients receiving azole antifungals should have their medication regimen analyzed for drug interactions when initiating and adjusting therapy; this may be done by use of the Lexi-Interact program within UpToDate. For additional information refer to the clinical topic on pharmacology of azoles.</p>
<p>§ After the 3-day loading dose, once or twice daily dosing of itraconazole dosing is used in mild to moderate blastomycosis in immunocompetent patients. Twice daily itraconazole dosing is used in severe blastomycosis and in immunocompromised patients. Three times daily itraconazole dosing is used in patients with CNS disease as an alternative to voriconazole.</p>
<p>¥ SUBA-itraconazole should not be used for treatment of CNS blastomycosis or in children.</p>
‡ Adjust dose based on trough serum concentrations obtained four to seven days after initiating therapy. Target goal trough is between 1 mcg/mL and 5.5 mcg/mL. Some UpToDate contributors prefer concentrations between 2 and 5.5 mcg/mL.</div><div class="graphic_reference">Adapted from: Chapman SW, Dismukes WE, Proia LA, et al. Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:1801.</div><div id="graphicVersion">Graphic 140275 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
